Biotech Active Stocks: MannKind Corporation (NASDAQ:MNKD), Inovio Pharmaceuticals (NYSEMKT:INO), Rexahn Pharmaceuticals (NYSEMKT:RNN), Peregrine Pharmaceuticals (NASDAQ:PPHM)

Inovio Pharmaceuticals Inc (NYSEMKT:INO) raises $63 million, secures capital needs for near-term trial advancement and preparation to enter Phase lll studies. Inovio Pharmaceuticals Inc (NYSEMKT:INO) dropped -1.96 percent to $3.51 yesterday on volume of INO 6.88million shares. The intra-day range of the stock was $3.50 to $3.71. Inovio Pharmaceuticals Inc (NYSEMKT:INO) has a market capitalization of $795.32million. After announcing two years ago that it would … Continue reading Biotech Active Stocks: MannKind Corporation (NASDAQ:MNKD), Inovio Pharmaceuticals (NYSEMKT:INO), Rexahn Pharmaceuticals (NYSEMKT:RNN), Peregrine Pharmaceuticals (NASDAQ:PPHM)

Investor’s Alert: BlackBerry Ltd (NASDAQ:BBRY), Zynga Inc (NASDAQ:ZNGA), American Airlines Group (NASDAQ:AAL), MannKind Corporation (NASDAQ:MNKD)

BlackBerry Ltd (NASDAQ:BBRY) has shared details of its next update for its BBM app for iOS and Android devices. BlackBerry Ltd (NASDAQ:BBRY) stock performance was 3.70% in last session and finished the day at $10.37. Traded volume was 26,605,132 million shares in the last session and the average volume of the stock remained 27.92 million shares. The beta of the stock remained 1.64. BlackBerry Ltd … Continue reading Investor’s Alert: BlackBerry Ltd (NASDAQ:BBRY), Zynga Inc (NASDAQ:ZNGA), American Airlines Group (NASDAQ:AAL), MannKind Corporation (NASDAQ:MNKD)

Biotech Runners: VIVUS (NASDAQ:VVUS), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA), MannKind Corporation (NASDAQ:MNKD)

VIVUS Inc. (NASDAQ:VVUS) stock was downgraded by analysts at JPMorgan Chase & Co. from an “overweight” rating to a “neutral” rating. They now have a $8.00 price target on the stock, down previously from $15.00. VIVUS, Inc. (NASDAQ:VVUS) stock performance was 1.00% in last session and finished the day at $6.09. Traded volume was 5,364,675 million shares in the last session and the average volume … Continue reading Biotech Runners: VIVUS (NASDAQ:VVUS), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA), MannKind Corporation (NASDAQ:MNKD)

Biotech Active Stocks: Ariad Pharmaceuticals (NASDAQ:ARIA), Rexahn Pharmaceuticals (NYSEMKT:RNN), Gilead Sciences (NASDAQ:GILD), MannKind Corporation (NASDAQ:MNKD)

ARIAD Pharmaceuticals, Inc., an oncology company, focuses on the discovery, development, and commercialization of medicines for cancer patients. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock performance was -3.34% in last session and finished the day at $8.69. Traded volume was 1,200.00 shares in the last session and the average volume of the stock remained 26.48 million shares. The beta of the stock remained 1.64. Ariad Pharmaceuticals, Inc. … Continue reading Biotech Active Stocks: Ariad Pharmaceuticals (NASDAQ:ARIA), Rexahn Pharmaceuticals (NYSEMKT:RNN), Gilead Sciences (NASDAQ:GILD), MannKind Corporation (NASDAQ:MNKD)

Active Watch List: Exxon Mobil Corporation (NYSE:XOM), Kinder Morgan, Inc. (NYSE:KMI), Aetna Inc. (NYSE:AET), Nationstar Mortgage Holdings Inc. (NYSE:NSM), MannKind Corp. (NASDAQ:MNKD)

Last week, Exxon Mobil Corporation (NYSE:XOM) rose on reporting a beyond expectations earnings of its third quarter financial results in its refining and chemicals business. The firm declared third quarter earnings of $1.89 per share, grew from $1.79 a share in the previous year phase. This surpassed analyst projections of $1.71 per share. CEO Rex Tillerson stated that addition across the firm’s exploration and production, … Continue reading Active Watch List: Exxon Mobil Corporation (NYSE:XOM), Kinder Morgan, Inc. (NYSE:KMI), Aetna Inc. (NYSE:AET), Nationstar Mortgage Holdings Inc. (NYSE:NSM), MannKind Corp. (NASDAQ:MNKD)

Trader’s Recap : MannKind Corp. (NASDAQ:MNKD), AbbVie Inc. (NYSE:ABBV), Cinemark Holdings Inc. (NYSE:CNK), LDR Holding Corporation (NASDAQ:LDRH), Stillwater Mining Co. (NYSE:SWC)

Equities research analysts at Goldman Sachs assumed coverage on shares of MannKind (NASDAQ:MNKD) in a research note issued to investors on Monday, TheFlyOnTheWall.com reports. The firm set a “neutral” rating and a $6.00 price target on the stock. MannKind Corp. (NASDAQ:MNKD) belongs to Healthcare sector. Its weekly performance is 8.70%. On last trading day company shares ended up $6.18. MannKind Corp. (NASDAQ:MNKD) distance from 50-day … Continue reading Trader’s Recap : MannKind Corp. (NASDAQ:MNKD), AbbVie Inc. (NYSE:ABBV), Cinemark Holdings Inc. (NYSE:CNK), LDR Holding Corporation (NASDAQ:LDRH), Stillwater Mining Co. (NYSE:SWC)